Pharmaceutical News

Big Pharma gets a bad rap these days due to patent expirations threatening some of the major players. But their juicy dividends are very attractive, and some pharmaceutical stocks have made great progress in developing a new pipeline of drugs that will replace lost revenue from previous blockbusters.

The Food and Drug Administration (FDA) has suggested more clinical trials to back up Watson Pharmaceuticals' New Drug Application (NDA 22-139) for Progesterone Vaginal Gel 8%.

On Tuesday, a group of ministers (GoM) led by agriculture minister Sharad Pawar will examine the proposed National Pharmaceutical Pricing Policy (NPPP) prepared by the ministry of chemicals and fertilisers.